Looking Into Ascendis Pharma's Recent Short Interest
Ascendis Pharma's (NYSE:ASND) short percent of float has risen 13.75% since its last report. The company recently reported that it has 3.35 million shares sold short, which is 8.52% of all regular sha
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.5% to 1,380.32 on the S&P Europe Select ADR Index. With the gain, the index is set to c
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
COPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced it will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024,
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Ascendis Pharma (ASND) said Wednesday that the UK's Medicines and Healthcare Products Regulatory Agency has granted marketing authorization for Yorvipath as a parathyroid hormone, or PTH, replacement
Express News | MHRA Approves YORVIPATH In Great Britain For Adults With Chronic Hypoparathyroidism
Express News | Morgan Stanley Maintains Equal-Weight on Ascendis Pharma, Maintains $116 Price Target
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains
$1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 15 years by 17.87% on an annualized basis producing an average annual return of 30.26%. Currently, Ascendis Pharma has a market
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
European equities traded in the US as American depositary receipts were treading water in Thursday morning session, nudging 0.006% higher to 1,330.06 on the S&P Europe Select ADR Index. From continent
Ascendis Pharma A/S Outlines Financial Strategy
Trending Stocks Today: Marin Software Shoots up 114.55% Post-Market
April 9th - US stocks trending post-market.Gainers: $Marin Software(MRIN.US)$ shoots up 114.55% to $0.62 with a turnover of $7.36 million. $Pricesmart(PSMT.US)$ up 4.1% to $86.5 with a turnover of $6.
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 10 years by 44.46% on an annualized basis producing an average annual return of 55.34%. Currently, Ascendis Pharma has a market
Subdued Growth No Barrier To Ascendis Pharma A/S' (NASDAQ:ASND) Price
Ascendis Pharma A/S' (NASDAQ:ASND) price-to-sales (or "P/S") ratio of 29.1x might make it look like a strong sell right now compared to the Biotechs industry in the United States, where around half of
Ascendis Pharma Is Maintained at Overweight by JP Morgan
Ascendis Pharma Is Maintained at Overweight by JP Morgan
Express News | Cantor Fitzgerald Reiterates Overweight on Ascendis Pharma, Maintains $173 Price Target
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday
European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.1% to 1,376.92 on the S&P Europe Select ADR Index. From continental Eur
GOP Committee Opposes Cannabis Banking Bill; Calls Marijuana 'Gateway Drug'
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
European equities traded in the US as American depositary receipts were trending higher Thursday morning, rising 0.56% to 1,371.10 on the S&P Europe Select ADR Index. From continental Europe, the gain
Ascendis Pharma Is Maintained at Overweight by Wells Fargo
Ascendis Pharma Is Maintained at Overweight by Wells Fargo
No Data